PIQ proteomics international laboratories ltd

Hi Eqz, I am just looking at App 4C Item 9 Estimated cash...

  1. 93 Posts.
    lightbulb Created with Sketch. 106
    Hi Eqz,

    I am just looking at App 4C Item 9 Estimated cash outflows for the next quarter:

    Column 1 Column 2
    0 R&D Expenditure $450
    1 Product manufacturing & operating costs $45
    2 Advertising & Marketing $50
    3 Staff costs $140
    4 Administration & Corporate costs $110
    5    
    6 Total Quarterly Costs $795
    7    
    8 Monthly Costs $265

    So the target as I saw it is to be monthly cashflow neutral by the end of the financial year which does not mean that the quarter will be cashflow neutral. Therefore by June they need to have revenue of $265 for the month.

    However, the R&D Expenditure is entitled to an R&D Tax Incentive of 43.5% which is $195 for the quarter or $65 for the month, assuming even expenditure.

    I would have thought that the target was cashflow neutral meaning $265k of revenue in June. However given that you will get the $65k back for June R&D payments later this year the revenue only needs to be about $200k to be neutral.

    This is a tripling of the revenue for the March Quarter but Promarker D was only launched in March so these should be the first full months of royalty revenue associated with it.

    Will see how they mark their report card after the quarter.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
29.0¢
Change
-0.015(4.92%)
Mkt cap ! $47.42M
Open High Low Value Volume
30.0¢ 31.0¢ 28.5¢ $191.2K 643.7K

Buyers (Bids)

No. Vol. Price($)
1 53694 29.5¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 51000 2
View Market Depth
Last trade - 15.36pm 26/06/2025 (20 minute delay) ?
PIQ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.